High risk individuals in COVID-19 pandemic; an updated review

被引:2
作者
Chegini, Rojin [1 ]
Bolurian, Alireza [2 ,3 ]
Mojtahedi, Zahra [4 ]
Hafizi, Masoud [5 ]
机构
[1] Isfahan Univ Med Sci, Esfahan, Iran
[2] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Nevada, Dept Hlth Care Adm & Policy, Sch Publ Hlth, Las Vegas, NV 89154 USA
[5] Shahrekord Univ Med Sci, Dept Infect Dis, Shahrekord, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2021年 / 7卷 / 02期
关键词
COVID-19; SARSCov2; severity; COVID-19 risk factors; Diabetes; Obesity; Pregnancy; Cancer; Chronic renal failure; Angiotensin-converting enzyme 2;
D O I
10.34172/ipp.2021.25
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In December 2019, cases of pneumonia with an unknown pathogen were reporting in Wuhan city, China. The World Health Organization (WHO) recognized it as a pandemic, on March 11, 2020. The most frequent site of involvement is the respiratory system. The most common symptoms include cough, fatigue and fever. In some cases, neurological, respiratory and gastrointestinal complications can lead to death. Inflammatory cytokines can play a major role in pathogen damage. Due to the pandemic of COVID-19 and its severe complications, it is critical to identify the high-risk groups. Since this disease has a rapid transmission, following the instructions announced by the WHO, prevention is vital, especially in people with risk factors for disease complications and mortality. According to the latest reports by CDC (Center for Disease Control and Prevention), older age and having some medical conditions such as smoking, obesity (BMI >= 30 kg/m(2)), chronic obstructive pulmonary disease (COPD), heart disease, cancer, solid organ transplant, type 2 diabetes mellitus, chronic renal failure, and sickle cell anemia in younger adults are known disease severity risk factor.
引用
收藏
页数:5
相关论文
共 37 条
  • [31] Management of sickle cell disease
    Steinberg, MH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) : 1021 - 1030
  • [32] COVID-19, Virology and Geroscience: A Perspective
    Vellas, C.
    Delobel, P.
    Barreto, P. De Souto
    Izopet, J.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2020, 24 (07) : 685 - 691
  • [33] Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
    Wang, Dawei
    Hu, Bo
    Hu, Chang
    Zhu, Fangfang
    Liu, Xing
    Zhang, Jing
    Wang, Binbin
    Xiang, Hui
    Cheng, Zhenshun
    Xiong, Yong
    Zhao, Yan
    Li, Yirong
    Wang, Xinghuan
    Peng, Zhiyong
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11): : 1061 - 1069
  • [34] Sickle cell disease
    Ware, Russell E.
    de Montalembert, Mariane
    Tshilolo, Leon
    Abboud, Miguel R.
    [J]. LANCET, 2017, 390 (10091) : 311 - 323
  • [35] Factors associated with COVID-19-related death using OpenSAFELY
    Williamson, Elizabeth J.
    Walker, Alex J.
    Bhaskaran, Krishnan
    Bacon, Seb
    Bates, Chris
    Morton, Caroline E.
    Curtis, Helen J.
    Mehrkar, Amir
    Evans, David
    Inglesby, Peter
    Cockburn, Jonathan
    McDonald, Helen, I
    MacKenna, Brian
    Tomlinson, Laurie
    Douglas, Ian J.
    Rentsch, Christopher T.
    Mathur, Rohini
    Wong, Angel Y. S.
    Grieve, Richard
    Harrison, David
    Forbes, Harriet
    Schultze, Anna
    Croker, Richard
    Parry, John
    Hester, Frank
    Harper, Sam
    Perera, Rafael
    Evans, Stephen J. W.
    Smeeth, Liam
    Ben Goldacre
    [J]. NATURE, 2020, 584 (7821) : 430 - +
  • [36] The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
    Ye, Qing
    Wang, Bili
    Mao, Jianhua
    [J]. JOURNAL OF INFECTION, 2020, 80 (06) : 607 - 613
  • [37] Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI [10.1056/NEJMoa2001017, 10.1172/JCI89857]